1Das M, Gillott DJ, Saridogan E, et al. Anti-MiJllerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycysfic ovary syndrome. Hum Reprod, 2008, 23(9): 2122-6,.
2Kevenaar ME, Themmen AP, van Kerkwijk AJ, et al. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Hum Reprod, 2009, 24(1): 241-9.
3Nilsson E, Rogers N, Skinner MK. Actions of anti-Mtillerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction, 2007, 134(2):209-21.
4Dumesic DA, Lesnick TG, Stassart JP, et al. InWafollicular anti- Mtillerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovu-latory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertiliza- tion and embryo transfer. Fertil Steril, 2009, 92(1):217-21.
5Teixeira J, Maheswaran S, Donahoe PK. Mtillerian inhibiting substance: An instructive developmental hormone with di- agnostic and possible therapeutic applications. Endocr Rev, 2001, 22(5):657-74.
6Salmon NA, Handyside AH, Joyce IM. Expression of Sox8, Sfl, Gata4, Wtl, Daxl, and Fog2 in the mouse ovarian follicle: Implications for the regulation of Amh expression. Mol Reprod Dev, 2005, 70(3):271-7.
7Falbo A, Rocca M, Russo T, et al. Serum and follicular anti- MiJllerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin. J Ovarian Res, 2010, 3(1): 16-21.
8Nardo LG, Yates AP, Roberts SA, et al. The relationships be- tween AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and with- out polycystic ovary syndrome. Hum Reprod, 2009, 24(11): 2917-23.
9Chen M J, Yang WS, Chen CL, et al. The relationship between anti-Mtillerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod, 2008, 23(4):952-7.
10Weenen C, Laven JS, von Bergh AR, et al. Anti-Miillerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod, 2004, 10(2):77-83.
二级参考文献13
1[1]Baarends WM,Uilenbroek JT,Kramer P,et al.Anti-mullerian hormone and anti-mullerian hormone type Ⅱ receptor messenger ribonucleic acid expression in rat ovaries during postnatal development,the estrous cycle,and gonadotropin-induced follicle growth.Endocrinol,1995,136:4951-4962.
2[2]Durlinger AL,Kramer P,Karels B,et al.Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary.Endocrinol,1999,140:5789-5796.
3[3]Durlinger AL,Gruijters MJ,Kramer P,et al.Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary.Endocrinol,2001,142:4891-4899.
4[4]Pigny P,Merlen E,Robert Y,et al.Elevated serum level of antimullerian hormone in patients with polycystic ovary syndrome:relationship to the ovarian follicle excess and to the follicular arrest.J Clin Endoerinol Metab,2003,88:5957-5962.
5[5]Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group:revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril,2004,81:19-25.
6[6]Andersen CY,Byskov AG.Estradiol and regulation of antiMullerian hormone,inhibin-A,and inhibin-B secretion:analysis of small antral and preovulatory human follicles'fluid.J Clin Endocrinol Metab,2006,91:4064-4069.
7[7]Weenen C,Laven JS,Von Bergh AR,et al.Anti-Mullerian hormone expression pattern in the human ovary:potential implications for initial and cyclic follicle recruitment.Mol Hum Reprod,2004,10:77-83.
8[8]Fallat ME,Siow Y,Marra M,et al.Mullerian-inhibiting substance in follicular fluid and serum:a comparison of patients with tubal factor infertility,polycystic ovary syndrome,and endometriosis.Fertil Steril,1997,67:962-965.
9[9]Petermann T,Codner E,Maliqueo M,et al.Increased antiMullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.J Clin Endoerinol Metab,2006,91:3105-3109.
10[10]Kevenaar ME,Themmen AP,Laven JS,et al.Anti-Mullerian hormone and anti-Mullerian hormone type Ⅱ receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.Hum Reprod,2007,22:1547-1554.
5Franks S,Gilling-Smith C,Watson H, et al. Insulin action in the normal and polycystic ovary [ J ]. Endocrinol Metab Clin North Am,1999,28(2) :361-378.
6Dewailly D,Pigny P, Soudan B, et al. Reconciling thedefi- nitions of polycystic ovary syndrome:The ovarian follicle number and serum anti-Mtillerian hormone concentrations aggregate with the markers of hyperandrogenism [ J ]. J Clin Endocrinol Metab,2010,95(9) :4399-4405.
7Xita N,Tsatsoulis A. Review:Fetal programming of poly- cystic ovary syndrome by androgen excess:evidence from experimental, clinical, and genetic association studies [ J]. J Clin Endocrinol Metab,2006,91 (5) : 1660-1666.
8Eldar-Geva T, Margalioth EJ, Gal M, et al. Serum anti-Mul- lerian hormone levels during controlled ovarian hyperstimu- lation in women with polycystic ovaries with and without hyperandrogenism [ J ]. Hum Reprod, 2005,20 ( 7 ) : 1814- 1819.
9Codner E, Ifiiguez G, Villarroel C, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus [ J ]. J Clin Endocrinol Metab, 2007,92(12) :4742-4746.
10Fleming R, Harborne L, MacLaughlin DT, et al. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment [ J ]. Fertil Steril, 2005,83 ( 1 ) : 130-136.
